Almost 1% of adults in China with an unexplained thickened wall of the heart’s main pumping chamber, called left ventricular…
Articles by Steve Bryson, PhD
A chronic cough was the only initial symptom in a 46-year-old man who was eventually diagnosed with Fabry disease,…
Modifying a potential gene therapy with a specific antibody increased its efficacy in cells that line blood vessels — cells…
Noninvasive quantitative magnetic resonance imaging, or qMRI, accurately detected excess globotriaosylceramide (Gb3), the fatty molecule that accumulates in people with…
Researchers detected a mutation in the GLA gene, which is defective in Fabry disease patients, in people with…
Pregnancy increased the severity and frequency of pain among women with Fabry disease who lived with moderate pain before…
Centogene has extended a collaboration deal with Takeda in which the two companies will continue to provide diagnostic…
Measures of heart function improved one to two years after treatment with 4D-310, an investigational gene therapy for Fabry…
Elfabrio (pegunigalsidase alfa) is as safe and effective as Fabrazyme (agalsidase beta) and can prevent kidney decline in adults…
4D Molecular Therapeutics (4DMT) has reached an agreement with the U.S. Food and Drug Administration (FDA) to lift the…